Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

4.07
-0.7700-15.91%
Pre-market: 4.130.0600+1.47%04:10 EDT
Volume:26.43M
Turnover:112.69M
Market Cap:1.68B
PE:-3.72
High:4.74
Open:4.66
Low:4.01
Close:4.84
52wk High:5.63
52wk Low:1.64
Shares:411.96M
Float Shares:339.00M
Volume Ratio:0.97
T/O Rate:7.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0941
EPS(LYR):-1.0941
ROE:-55.50%
ROA:-27.30%
PB:2.40
PE(LYR):-3.72

Loading ...

May 09, 2023

Major Issues Report

8-K - Current report
Apr 24, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Major Issues Report

8-K/A [Amend] - Current report
Jan 23, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 11, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 18, 2022

Major Issues Report

8-K - Current report
Nov 18, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]